Nuclear Morphotype-Based Stem Cell Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively identify and isolate tumor stem cells, which are crucial for understanding and addressing tumor growth and differentiation, as they are not described in existing literature.
Innovation Solution
The process involves identifying and classifying organ-specific and tumor stem cells based on unique nuclear morphotypes, such as bell-shaped nuclei, and their modes of division, allowing for their isolation and study in cell cultures and tissue samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional methods are used to identify tumor stem cells, then the process is simple and quick, but the identification accuracy is insufficient because tumor stem cells are not described in existing literature and current methods fail to effectively identify them
Solution Approach 1:
The patent employs nuclear morphotype classification where tumor stem cells are identified by their distinctive nuclear characteristics (size, shape, chromatin pattern) rather than traditional antigenic markers. This morphological 'color coding' system enables visual differentiation and accurate identification of tumor stem cells without requiring complex molecular assays, thereby improving identification accuracy while maintaining relative simplicity
Solution Approach 2:
The invention shifts the identification parameters from antigenic molecules to nuclear morphological parameters (nuclear size, shape, chromatin density). By changing the measurement parameters from molecular biology to histomorphology, the method achieves effective tumor stem cell identification where previous methods failed, resolving the contradiction between accuracy and complexity
2Reliability
If tumor stem cells are isolated and studied using new morphotype-based methods, then effective preventative and therapeutic regimens can be discovered, but the process requires complex classification and manipulation procedures
Solution Approach 1:
The patent segments the tumor cell population into distinct morphotypes based on nuclear characteristics, allowing isolation and study of tumor stem cells separately from differentiated tumor cells. This segmentation enables targeted therapeutic development against the stem cell compartment, improving therapeutic reliability while organizing the complexity into manageable morphological categories
Solution Approach 2:
The invention introduces nuclear morphotype classification as an intermediary system between traditional tumor cell identification and modern molecular stem cell markers. This intermediary approach provides a practical bridge that enables stem cell isolation and manipulation without requiring direct access to undefined molecular markers, thereby achieving therapeutic effectiveness through a structured classification framework
Data Source
AI summary
Methods for identifying stem cells and other cells specific to embryogenesis and carcinogenesis, classifying tissue samples, diagnosing precancerous and cancerous or atherosclerotic lesions, testing the value of anticancer agents, discovering macromolecules specifically expressed in particular cell types, using stem cells in restorative tissue therapy as well as methods for preparing tissue samples so heteromorphic nuclear morphotypes remain intact are disclosed.